Capital World Investors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-1,057,000
| Closed | -$16.1M | – | 550 |
|
|
2018
Q2 | $16.1M | Sell |
1,057,000
-4,076,000
| -79% | -$62.2M | ﹤0.01% | 475 |
|
|
2018
Q1 | $115M | Buy |
5,133,000
+2,305,000
| +82% | +$51.8M | 0.03% | 283 |
|
|
2017
Q4 | $85.2M | Buy |
2,828,000
+275,000
| +11% | +$8.28M | 0.02% | 309 |
|
|
2017
Q3 | $96.2M | Hold |
2,553,000
| – | – | 0.02% | 297 |
|
|
2017
Q2 | $71.2M | Hold |
2,553,000
| – | – | 0.02% | 319 |
|
|
2017
Q1 | $87.8M | Sell |
2,553,000
-950,000
| -27% | -$32.7M | 0.02% | 298 |
|
|
2016
Q4 | $101M | Sell |
3,503,000
-261,000
| -7% | -$7.53M | 0.03% | 281 |
|
|
2016
Q3 | $120M | Hold |
3,764,000
| – | – | 0.03% | 266 |
|
|
2016
Q2 | $122M | Buy |
3,764,000
+430,000
| +13% | +$14M | 0.03% | 259 |
|
|
2016
Q1 | $93.2M | Buy |
3,334,000
+590,000
| +22% | +$16.5M | 0.03% | 281 |
|
|
2015
Q4 | $97.8M | Sell |
2,744,000
-377,000
| -12% | -$13.4M | 0.03% | 284 |
|
|
2015
Q3 | $103M | Sell |
3,121,000
-300,756
| -9% | -$9.95M | 0.03% | 284 |
|
|
2015
Q2 | $143M | Sell |
3,421,756
-29,644
| -0.9% | -$1.24M | 0.04% | 273 |
|
|
2015
Q1 | $112M | Buy |
3,451,400
+2,108,400
| +157% | +$68.7M | 0.03% | 294 |
|
|
2014
Q4 | $42.6M | Buy |
1,343,000
+530,203
| +65% | +$16.8M | 0.01% | 382 |
|
|
2014
Q3 | $20.1M | Buy |
812,797
+412,797
| +103% | +$10.2M | 0.01% | 431 |
|
|
2014
Q2 | $9.04M | Hold |
400,000
| – | – | ﹤0.01% | 485 |
|
|
2014
Q1 | $9.73M | Buy |
400,000
+150,000
| +60% | +$3.65M | ﹤0.01% | 472 |
|
|
2013
Q4 | $6.25M | Hold |
250,000
| – | – | ﹤0.01% | 469 |
|
|
2013
Q3 | $6.87M | Buy |
+250,000
| New | +$6.87M | ﹤0.01% | 463 |
|